BioVie and Liberty Star Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Access the interviews in their entirety at:
BIVI: https://www.redchip.com/assets/access/bivi_access
LBSR: https://www.redchip.com/assets/access/lbsr_access
In an exclusive interview, Cuong Do, President and CEO of BioVie, appears on the RedChip Small Stocks Big Money™ show on Bloomberg TV to share how BioVie is unlocking the science of longevity through novel therapeutics targeting neurodegenerative diseases and advanced liver conditions. Do highlights the Company's lead drug candidate, bezisterim, a first-in-class small molecule designed to combat chronic inflammation and insulin resistance-key drivers in Alzheimer's and Parkinson's disease, as well as Long COVID. He also discusses BIV201, BioVie's Orphan-designated liver therapy being developed to treat - and may become the first approved treatment - for ascites, an end-stage liver disease condition of 50%+ mortality rate in 12 months. With multiple clinical programs advancing across Phase 2 and Phase 3 trials and a clear path toward commercialization, BioVie is positioned at the forefront of transformative healthcare innovation.
Pete O'Heeron, Chairman of Liberty Star, and Liberty Star board member Gerardo King, appear on the RedChip Small Stocks Big Money™ show on Bloomberg TV to highlight the Company's dual-track strategy targeting high-grade gold and large-scale copper-gold mineralization in Arizona. They discuss recent bonanza-grade assay results from the Red Rock Canyon Gold Project, where surface samples have returned values as high as 107.5 g/t gold, and the validation of a porphyry copper system at the Hay Mountain Project through Liberty Star's 2024 drill campaign. With gold prices near all-time highs and copper demand surging amid global electrification, Liberty Star is actively pursuing a joint venture to accelerate project development while minimizing shareholder dilution. The company's experienced leadership and strategic positioning in one of North America's most prolific mining regions underscore its potential to unlock significant value through near- and long-term exploration success.
BIVI and LBSR are clients of RedChip Companies. Please read our full disclosure at https://www.redchip.com/legal/disclosures.
About BioVie Inc.
BioVie Inc. (NASDAQ:BIVI) is a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders (Long COVID, Alzheimer's disease and Parkinson's disease) and advanced liver disease. In neurodegenerative disease, the Company's drug candidate bezisterim inhibits inflammatory activation of extracellular signal-regulated kinase and the transcription factor nuclear factor-kB, and the associated neuroinflammation and insulin resistance but not ERK and NFkB homeostatic functions (e.g., insulin signaling and neuron growth and survival). Both neuroinflammation and insulin resistance are drivers of AD and PD. Persistent systematic inflammation and neuroinflammation are key features in patients with neurological symptoms of Long COVID. In liver disease, the Company's Orphan drug candidate BIV201 (continuous infusion terlipressin), with FDA Fast Track status, is being evaluated and discussed with guidance received from the FDA regarding the design of Phase 3 clinical testing of BIV201 for the reduction of further decompensation in participants with liver cirrhosis and ascites. The active agent is approved in the U.S. and in about 40 countries for related complications of advanced liver cirrhosis. For more information, visit www.bioviepharma.com.
About Liberty Star
Liberty Star Uranium & Metals Corp. (LBSR:OTCQB), d/b/a Liberty Star Minerals, is an Arizona-based mineral exploration company engaged in the acquisition, exploration, and development of mineral properties in Arizona and the southwest USA. Currently the company controls properties that are located over what management considers some of North America's richest mineralized regions for copper, gold, silver, molybdenum (moly), and associated metals. The Company's premiere property is the Hay Mountain property (exploration stage) for porphyry copper, gold, moly and other commercially important minerals. Specific targets have been selected to explore for near-surface and deep-seated ore bodies, of which there are numerous analogs nearby. Contiguous with the primary Hay Mountain porphyry exploration target, and part of the overall Hay Mountain property, is an increasingly attractive area of exploration stage gold mineralization denominated Red Rock Canyon. Red Rock Canyon exhibits what we believe are extensive, promising hydrothermal associated gold-bearing structures that are documented in historical public and Company records. View numerous geoscientific reports on our website. The Hay Mountain & Red Rock Canyon properties are in Cochise County (southeast) Arizona, USA.
Follow Liberty Star Minerals on Facebook, LinkedIn & [X]Twitter
About RedChip Companies
RedChip Companies, an Inc. 5000 company, is an international investor relations, media, and research firm focused on microcap and small-cap companies. For 33 years, RedChip has delivered concrete, measurable results for its clients. Our newsletter, Small Stocks, Big Money™, is delivered online weekly to 60,000 investors. RedChip has developed the most comprehensive service platform in the industry for microcap and small-cap companies. These services include the following: a worldwide distribution network for its stock research; retail and institutional roadshows in major U.S. cities; outbound marketing to stock brokers, RIAs, institutions, and family offices; a digital media investor relations platform that has generated millions of unique investor views; investor webinars and group calls; a television show, Small Stocks, Big Money™, which airs weekly on Bloomberg US; TV commercials in local and national markets; corporate and product videos; website design; and traditional investor relation services, which include press release writing, development of investor presentations, quarterly conference call script writing, strategic consulting, capital raising, and more.
To learn more about RedChip's products and services, please visit:
https://www.redchip.com/corporate/investor_relations
"Discovering Tomorrow's Blue Chips Today"™
Follow RedChip on LinkedIn: https://www.linkedin.com/company/redchip/
Follow RedChip on Facebook: https://www.facebook.com/RedChipCompanies
Follow RedChip on Instagram: https://www.instagram.com/redchipcompanies/
Follow RedChip on Twitter: https://twitter.com/RedChip
Follow RedChip on YouTube: https://www.youtube.com/@redchip
Follow RedChip on Rumble: https://rumble.com/c/c-3068340
Subscribe to our Mailing List: https://www.redchip.com/newsletter/latest
Contact:
Dave GentryRedChip Companies Inc.1-407-644-4256info@redchip.com
--END--
SOURCE: RedChip Companies, Inc.
View the original press release on ACCESS Newswire
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
28 minutes ago
- Yahoo
Alphabet (GOOGL) Gets $190 Price Target Ahead of Earnings, Analyst Sees Favorable Setup
Alphabet Inc. (NASDAQ:) is one of the . On July 21, Wolfe Research analyst Shweta Khajuria reiterated an 'Outperform' rating on the stock with a $190.00 price target. The rating affirmation comes ahead of Alphabet's second-quarter earnings report scheduled for Tuesday, July 22nd. The firm noted that even though it's going to 'skew long into the print,' there may not be enough investor focus as it would be diverted to the upcoming Search ruling anticipated in August. The firm highlighted how Alphabet shares have outperformed the S&P 500 by 1 percentage point since the last earnings release, driven by a 'friendly setup,' improving advertising environment, and its AI narrative for Gemini models. Photo by on Unsplash Wolfe Research noted that it will be all ears for Alphabet's updates on the AI mode and AI overview monetization during the earnings call. Any metric disclosures may move beyond clicks growth and come during Q3 call or later. Alphabet Inc. (NASDAQ:GOOGL) is an American multinational technology conglomerate holding company wholly owning the internet giant Google, amongst other businesses. While we acknowledge the potential of GOOGL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure: None. Sign in to access your portfolio
Yahoo
28 minutes ago
- Yahoo
Apple (AAPL) Stock Rated Hold as HSBC Flags AI Letdown and Tariff Risks
Apple Inc. (NASDAQ:) is one of the . On July 18, HSBC maintained a 'Hold' rating on the stock with a $220 price target. The firm has quoted a '5% regulatory discount' and warned that tariff and legal uncertainties may limit near-term upside. HBSC analysts claim that Apple's AI efforts for driving hardware upgrades through artificial intelligence have been falling short. Therefore, it needs a more compelling AI experience to revive AI sales. 'The iPhone still represents about half of Apple's sales,' HSBC wrote. But 'initial hopes that AI would accelerate the renewal cycle have been short-lived.' According to the bank, Apple Intelligence has 'so far failed to trigger significant improvement in user experience.' A delayed AI-powered Siri implies users may be delaying iPhone upgrades, which is why the company is relying on hardware upgrades to boost demand. 'Better specs with iPhone 17 in September should entertain the demand, in-line with what has been seen with the iPhone 16.' Tariffs are also a major concern for the company. The firm believes that the company 'cannot re-localise production fast enough to avoid U.S. tariff hikes.' Apple is a technology company known for its consumer electronics, software, and services. While we acknowledge the potential of AAPL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure: None. Sign in to access your portfolio
Yahoo
28 minutes ago
- Yahoo
Microsoft (MSFT) Gets $525 Price Target as AI and Cloud Demand Remain Strong
Microsoft Corporation (NASDAQ:) is one of the . On July 21, RBC Capital analyst Rishi Jaluria reiterated an 'Outperform' rating on the stock with a $525.00 price target. The firm's channel checks reveal 'healthy cloud' conditions and 'phased Copilot rollouts' across Microsoft's enterprise customer base. The channel checks included system integrators, cloud consulting firms, and also large enterprise-focused resellers with visibility into Azure deployments and AI adoption efforts, all of which described the overall tone as 'constructive.' Moreover, Azure's core workloads are staying steady while AI-related interest continues to build. In particular, Microsoft Copilot is being mentioned more frequently in expansion and renewal conversations regardless of customers remaining in pilot or department-level usage phases. 2nix Studio / The firm has also highlighted how commercial structures are evolving, with partners signing shorter contracts and even mid-contract adjustments tied to AI rollout timing. However, issues regarding internal readiness are limiting broader adoption. Microsoft Corporation (NASDAQ:MSFT) provides AI-powered cloud, productivity, and business solutions, focusing on efficiency, security, and AI advancements. While we acknowledge the potential of MSFT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure: None.
